506 NEWSLETTER 2021 • The Board authorized the acquisition of the sole control of Doosan Infracore Co., and its certain subsidiaries ultimately byHyundai Heavy Industries Holdings Co., Ltd. (01.04.2021, 21-18/221-93) • The Board authorized the acquisition of the sole control of Alexion Pharmaceuticals, Inc. by AstraZeneca PLC. (01.04.2021, 21-18/219-92) • The Board authorized the acquisition of the sole control of Indukern S.A. and its subsidiaries via Ravago Chemicals S.A., which is under the sole control of Ravago S.A. (01.04.2021, 21-18/218-91) • The Board authorized the acquisition of certain shares of Yapı Kredi Koray Gayrimenkul Yatırım Ortaklığı A.Ş. by Koray Gayrimenkul ve Yatırım A.Ş. (01.04.2021, 21-18/217-90) • The Board authorized the acquisition of certain shares of SBS Bilimsel Bio Çözümler Sanayi ve Ticaret A.Ş., which is currently under the sole control of Diffusion Capital Fund Cooperatief UA by Ak Portföy Yönetimi A.Ş. First Venture Capital Investment Fund and Ak Portföy Yönetimi A.Ş Second Venture Capital Investment Fund, which are represented byAk Portföy Yönetimi A.Ş. (01.04.2021, 21-18/215-88) • The Board authorized the acquisition of the sole control of Farhym Otomotiv Sanayi ve Ticaret Ltd. Şti. by Makel Yalıtım ve Üretim Teknolojileri Sanayi ve Ticaret A.Ş. (08.04.2021, 21-20/242-103) • The Board authorized the acquisition of the joint control of Dgpays S.à.r.l. and, indirectly, DGPays Bilişim Hizmetleri A.Ş and its subsidiaries by Goldman Sachs Group Inc. via ELQ Lux Holding S.à.r.l. (08.04.2021, 21-20/240-102) • The Board authorized the acquisition of Bioclinica Holding I LP by eResearchTechnology, Inc. (08.04.2021, 21-20/238101)
RkJQdWJsaXNoZXIy MjUzNjE=